Language selection

Search

2014-02-26 - Female - 34 Years old

900066310

Adverse reaction report number 900066310
Latest AER version number 0
Market authorization holder AER number ALL1-2014-01113
Initial received date 2014-02-26
Latest received date 2014-02-26
Age 34 Years
Gender Female
Weight N/A
Type of report Spontaneous
Reporter type Consumer Or Other Non Health Professional
Source of report MAH
Report outcome Recovered/resolved
Serious report? Yes

Reason for seriousness

Death
Disability
Cogenital anomaly
Life threateting
Hospitalization Yes
Other medically important

Product information

Product description Dosage form Health product role Route of administration Dose Frequency Therapy duration Indication(s)
ADDERALL XRSuspectOral40 Milligram1 every 1 Day(s) Product used for unknown indication
ADDERALL XRCAPSULE, EXTENDED RELEASESuspectOral40 Milligram1 every 1 Day(s) Product used for unknown indication

Adverse reaction term information

MedDRA version: v.21.1
Adverse reaction terms Reaction duration
Amnesia
Decreased appetite
Disturbance in attention
Energy increased
Impaired driving ability
Impulse-control disorder
Insomnia
Paranoia
Psychotic disorder
Weight decreased
Date modified: